EchoSolv AS vs Rapid PE Triage and Notification (PETN)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

EchoSolv AS

by Echo IQ

Rapid PE Triage and Notification (PETN)

by RapidAI (formerly iSchemaView)

AI Verdict

EchoSolv AS is an AI-powered clinical decision support tool for identifying patients at risk for severe aortic stenosis based on echocardiogram measurements. In contrast, Rapid PE Triage and Notification utilizes AI to detect suspected central pulmonary embolisms from CTPA images. While both are FDA-cleared AI solutions enhancing cardiovascular care and clinical workflows, they target distinct cardiac conditions and employ different diagnostic imaging modalities.

Choose EchoSolv AS if…

Choose EchoSolv AS if your cardiology department needs to efficiently identify patients at high risk for severe aortic stenosis from echocardiogram measurements. This tool is ideal for providing consistent, AI-powered clinical decision support and prioritizing studies for closer review without requiring EMR integration, streamlining the review process for cardiologists.

View EchoSolv AS →

Choose Rapid PE Triage and Notification (PETN) if…

Choose Rapid PE Triage and Notification if your emergency department or radiology practice requires rapid, AI-powered detection and notification of suspected central pulmonary embolisms from CTPA images. This tool is best suited for accelerating critical PE care pathways by immediately triaging cases and sending real-time alerts to clinicians in time-sensitive situations.

View Rapid PE Triage and Notification (PETN) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	EchoSolv AS	Rapid PE Triage and Notification (PETN)
Pricing	Unknown	Contact for pricing
Deployment	Cloud-based	On-premise Rapid Server (dedicated or virtual) within hospital LAN/firewall, or Rapid Edge Cloud Platform.
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoSolv AS

EchoSolv AS emphasizes ease of integration by not requiring EMR integration and analyzing numerical measurements rather than raw images, simplifying data input and workflow adoption. Its ultra-fast risk detection in under 3 seconds further enhances its practical usability within existing clinical workflows.

Clinical Value

EchoSolv AS

EchoSolv AS is FDA-cleared and has demonstrated near-perfect accuracy in detecting severe aortic stenosis, outperforming traditional clinical interpretation in validation studies with an AUC of 0.986. It also provides 'second reader support' and can identify high-risk patients who may not meet conventional clinical guidelines, offering a comprehensive approach to decision support.

Pricing & Value

EchoSolv AS

EchoSolv AS operates on a subscription-based model and has identified a clear reimbursement pathway through Miscellaneous Code 93799, offering a fee-per-use rate of US$100-US$150. This provides more transparency and a defined monetization strategy for hospitals compared to Tool B's undisclosed enterprise-level licensing.

Enterprise Readiness

Rapid PE Triage and Notification (PETN)

Rapid PE Triage and Notification offers greater deployment flexibility with both on-premise (dedicated or virtual server) and cloud platform options, catering to a wider range of enterprise IT infrastructures and security preferences. Both tools are FDA-cleared, HIPAA compliant, and have BAAs.

Innovation

Rapid PE Triage and Notification (PETN)

Rapid PE Triage and Notification demonstrates stronger innovation by leveraging AI for rapid CTPA image analysis and real-time, multi-channel notifications (PACS, email, mobile app) for a critical, time-sensitive condition like pulmonary embolism. This directly accelerates acute care pathways and significantly impacts emergency patient outcomes.

Support & Docs

Rapid PE Triage and Notification (PETN)

RapidAI clearly states that its annual subscription model includes comprehensive support, such as 24/7 live support and access to live and recorded training sessions. While EchoSolv AS mentions documentation, it lacks explicit details regarding the breadth and availability of its ongoing customer support services.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	EchoSolv AS	Rapid PE Triage and Notification (PETN)
Name	EchoSolv AS	Rapid PE Triage and Notification (PETN)
Company	Echo IQ	RapidAI (formerly iSchemaView)
Primary Function	AI-powered clinical decision support platform that analyzes echocardiograms to identify patients at risk for severe aortic stenosis.	AI-powered software that analyzes CTPA images to rapidly identify and notify clinicians of suspected central pulmonary embolisms.
AI Analysis Target	Echocardiograms (analyzes numerical measurements, not images)	CTPA images
Condition Detected	Severe Aortic Stenosis (sAS)	Suspected central pulmonary embolism (PE)
Key Workflow Integration/Notification	Designed to fit existing workflows (no EMR integration required, integrates with PACS). Ultra-fast risk detection (under 3 seconds). Second reader support to help prioritize studies.	Workflow triage and prioritization. Real-time notifications to clinicians (PACS, email, mobile app). Mobile and desktop application access.

Videos

Demos, reviews, and walkthroughs featuring EchoSolv AS and Rapid PE Triage and Notification (PETN).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific clinical conditions do these AI tools help diagnose or manage?

EchoSolv AS is designed to identify patients at risk for severe aortic stenosis (sAS) by analyzing echocardiograms. Rapid PE Triage and Notification (PETN), on the other hand, focuses on rapidly identifying suspected central pulmonary embolisms (PE) from CTPA images.

What type of data do these AI tools analyze?

EchoSolv AS analyzes numerical measurements from echocardiograms, not the images themselves, to provide severe AS probability and guideline checks. In contrast, Rapid PE Triage and Notification analyzes CTPA (CT Pulmonary Angiography) images to detect suspected central pulmonary embolisms.

How do these tools integrate into existing clinical workflows?

EchoSolv AS is designed to fit existing workflows, integrating with PACS and explicitly stating no EMR integration is required. Rapid PE Triage and Notification provides workflow triage and prioritization with real-time notifications to clinicians via PACS, email, and a mobile app, operating in parallel with the standard of care.

Which medical specialties are these tools primarily designed for?

EchoSolv AS is primarily intended for Cardiology and Cardiothoracic Surgery. Rapid PE Triage and Notification is designed for use by specialists in Cardiology, Emergency Medicine, and Radiology.

What is the primary output or actionable information provided by each tool?

EchoSolv AS provides AI-powered clinical decision support for severe AS probability, consistent guideline checks from measurements, and second reader support to help prioritize studies. Rapid PE Triage and Notification detects suspected central pulmonary embolism, offers workflow triage and prioritization, and sends real-time notifications to clinicians.